Dabur

465.10
-5.10
(-1.08%)
Market Cap
83,334.40 Cr
EPS
10.40
PE Ratio
46.65
Dividend Yield
1.72 %
52 Week High
672.00
52 Week Low
433.30
PB Ratio
7.64
Debt to Equity
0.13
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from39 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy+35.90 %
+35.90 %
Hold
Hold+43.59 %
+43.59 %
Sell
Sell+20.51 %
+20.51 %

Company News

View All News
Caret
positive
Dabur India enters nutraceuticals segment with 'Siens by Dabur', a D2C wellness brand offering science-backed supplements in Beauty and Skin Health, Daily Wellness, and Gut Health categories. Products include Marine Collagen, multivitamins, Omega-3 softgels, and probiotics, available on major e-commerce platforms including DaburShop.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,194.00
#1 1,22,413.10
64.42
#1 14,365.10
6.53
-561
#1 121.76
39.81
465.10
#2 83,334.40
#4 46.65
#2 12,886.40
#5 7.61
#1 1,811
#7 -8.35
38.67
2,399.70
65,233.00
45.41
5,757.00
9.04
1,324
-6.53
38.33
13,440.00
43,377.30
60.75
4,258.00
7.57
675
1.10
38.13
10,390.00
33,782.70
63.53
2,659.20
6.40
412
60.14
71.55
563.35
24,891.40
30.44
3,624.90
4.32
724
10.49
36.88
306.00
9,997.80
136.45
1,969.60
#1 29.98
111
-18.03
55.35
90.15
2,444.40
59.31
178.30
8.65
40
-51.48
37.64
171.46
2,375.40
#1 19.52
1,028.80
3.10
155
-12.92
45.17
180.15
270.40
102.94
33.10
25.86
2
16.67
49.64
Forecast
Actual
Growth Rate
Revenue Growth
7.61 %
Net Income Growth
6.47 %
Cash Flow Change
35.27 %
ROE
-2.44 %
ROCE
-3.02 %
EBITDA Margin (Avg.)
2.66 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
1,990
1,949
2,011
2,027
2,064
2,013
2,071
1,936
1,980
1,872
2,043
2,033
2,106
2,155
2,206
2,275
2,194
2,347
2,294
2,427
1,941
2,052
2,604
2,810
2,422
2,696
2,930
3,039
2,617
2,923
3,110
3,144
2,799
3,240
3,321
3,382
2,944
3,479
3,180
3,484
2,971
Expenses
1,604
1,586
1,555
1,594
1,595
1,603
1,573
1,519
1,497
1,496
1,539
1,563
1,548
1,695
1,674
1,754
1,746
1,836
1,762
1,880
1,534
1,563
1,947
2,155
1,895
2,060
2,197
2,314
2,150
2,279
2,386
2,434
2,268
2,526
2,543
2,588
2,348
2,694
2,476
2,673
2,403
EBITDA
385
363
456
433
469
410
498
417
483
376
504
470
558
460
532
521
448
511
532
547
408
488
657
655
527
637
733
724
467
644
724
710
530
714
778
795
595
784
704
810
568
Operating Profit %
18 %
17 %
20 %
19 %
21 %
18 %
21 %
18 %
22 %
16 %
21 %
21 %
24 %
19 %
21 %
20 %
18 %
19 %
20 %
20 %
18 %
21 %
23 %
21 %
19 %
21 %
22 %
21 %
15 %
19 %
20 %
20 %
15 %
19 %
21 %
21 %
17 %
20 %
18 %
20 %
15 %
Depreciation
28
33
33
32
36
34
36
33
40
39
40
41
43
43
43
45
46
53
55
54
59
57
60
57
67
61
63
63
65
68
71
71
102
97
98
97
107
109
111
109
117
Interest
10
12
13
11
13
12
17
14
12
13
13
13
13
15
16
17
12
15
15
11
9
8
8
7
9
8
8
11
12
12
15
19
32
24
28
37
35
33
47
44
39
Profit Before Tax
352
324
415
395
420
364
446
370
431
324
451
416
502
402
474
460
389
443
462
482
340
424
590
591
452
568
661
650
390
564
638
620
396
593
651
661
453
643
546
658
412
Tax
67
62
75
77
87
70
87
75
98
59
88
83
105
72
96
92
18
79
58
84
59
83
107
98
74
130
156
146
95
123
147
144
104
137
144
155
111
148
128
142
99
Net Profit
285
263
340
318
333
294
358
295
334
265
363
333
397
330
378
367
372
364
404
399
282
341
483
494
377
438
505
504
294
441
491
477
293
457
507
506
341
494
418
516
313
EPS in ₹
1.62
1.49
1.94
1.81
1.88
1.66
2.03
1.67
1.89
1.50
2.05
1.89
2.25
1.87
2.13
2.07
2.10
2.06
2.28
2.25
1.59
1.93
2.73
2.78
2.14
2.47
2.85
2.85
1.66
2.49
2.77
2.69
1.70
2.62
2.91
2.90
1.97
2.82
2.40
2.95
1.81

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
6,106
6,932
7,732
8,702
8,437
9,354
10,847
12,285
13,654
15,123
Fixed Assets
1,877
1,728
1,958
2,028
1,969
2,253
2,243
2,308
3,579
3,815
Current Assets
2,731
3,216
3,115
3,440
3,586
4,880
4,776
4,317
4,249
5,680
Capital Work in Progress
50
45
42
42
64
147
147
168
175
232
Investments
406
2,630
3,240
3,805
3,359
2,800
4,160
6,220
6,265
6,933
Other Assets
3,773
2,529
2,492
2,827
3,045
4,155
4,297
3,590
3,635
4,143
Total Liabilities
6,106
6,932
7,732
8,702
8,437
9,354
10,847
12,285
13,654
15,123
Current Liabilities
2,419
2,254
2,225
2,434
2,660
2,464
2,934
3,323
3,609
3,930
Non Current Liabilities
316
487
636
534
113
248
213
540
604
889
Total Equity
3,372
4,192
4,872
5,733
5,663
6,642
7,700
8,422
9,441
10,303
Reserve & Surplus
3,179
3,995
4,671
5,530
5,455
6,429
7,487
8,205
8,796
9,689
Share Capital
176
176
176
176
177
177
177
177
177
177

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-246
82
81
-27
-52
54
97
38
-130
-119
Investing Activities
-876
-730
-807
-541
338
-517
-1,404
-1,273
-583
-971
Operating Activities
1,047
1,187
1,227
1,092
1,499
1,614
2,115
1,802
1,488
2,014
Financing Activities
-417
-374
-339
-577
-1,888
-1,043
-613
-491
-1,035
-1,161

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
67.38 %
67.36 %
67.36 %
67.37 %
67.38 %
67.24 %
67.24 %
66.24 %
66.24 %
66.23 %
66.23 %
66.24 %
66.25 %
66.24 %
66.25 %
66.26 %
66.27 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
15.83 %
14.98 %
15.04 %
13.27 %
12.68 %
DIIs
5.28 %
4.61 %
3.36 %
3.51 %
3.78 %
3.98 %
5.77 %
7.61 %
8.43 %
8.87 %
8.61 %
10.35 %
12.56 %
13.56 %
13.67 %
14.92 %
15.69 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.43 %
5.29 %
5.28 %
5.55 %
5.28 %
5.18 %
4.47 %
4.34 %
4.32 %
4.29 %
4.26 %
4.28 %
4.19 %
4.03 %
3.92 %
4.34 %
4.19 %
Others
21.91 %
22.74 %
23.99 %
23.57 %
23.56 %
23.61 %
22.53 %
21.82 %
21.00 %
20.61 %
20.90 %
19.13 %
1.17 %
1.18 %
1.12 %
1.20 %
1.17 %
No of Share Holders
2,96,439
3,18,852
3,59,529
4,33,443
4,82,133
4,83,560
4,57,490
4,43,618
4,48,975
4,44,832
4,33,501
4,39,123
4,34,823
4,35,213
4,30,436
5,10,298
5,05,557

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.25 7.5 2.75 3 4.75 5.2 5.2 5.5 0.00
Dividend Yield (%) 0.00 0.69 1.83 0.61 0.56 0.89 0.97 0.99 1.09 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
07 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
07 Aug 2025 480.60 469.70
18 Jul 2025 DIVIDEND Dividend
₹ 5.25 /share
18 Jul 2025 480.60 469.70
07 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 May 2025 512.65 480.60
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2025 504.00 518.15
08 Nov 2024 DIVIDEND Dividend
₹ 2.75 /share
08 Nov 2024 535.85 534.30
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 661.00 535.85
08 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
08 Aug 2024 599.10 639.40
22 Jul 2024 DIVIDEND Dividend
₹ 2.75 /share
19 Jul 2024 507.55 632.90
10 Nov 2023 DIVIDEND Dividend
₹ 2.75 /share
10 Nov 2023 517.15 535.80
24 Jul 2023 DIVIDEND Dividend
₹ 2.70 /share
21 Jul 2023 537.95 565.20
04 Nov 2022 DIVIDEND Dividend
₹ 2.50 /share
03 Nov 2022 532.15 555.90
25 Jul 2022 DIVIDEND Dividend
₹ 2.70 /share
21 Jul 2022 538.05 576.10
12 Nov 2021 DIVIDEND Dividend
₹ 2.50 /share
11 Nov 2021 597.05 596.80
02 Aug 2021 DIVIDEND Dividend
₹ 3.00 /share
29 Jul 2021 545.25 600.50

Announcements

Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015.2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMay 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 22, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendMay 21, 2025
Fixation Of Record Date For Ascertainment Of Shareholders Entitled To Receive The DividendMay 21, 2025
Intimation Of Book Closure For Declaration Of DividendMay 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 07, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 07, 2025
Submission Of Code Of Practices And Procedures For Fair Disclosure Of UPSIMay 07, 2025
Corporate Action-Board approves DividendMay 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 07, 2025
Audited Financial And Segment Wise Results For The Quarter And Year Ended March 31 2025May 07, 2025
Board Meeting Outcome for Audited Financial And Segment Wise Results For The Quarter And Year Ended March 31 2025 Declaration Of Dividend And Fixing Of Annual General MeetingMay 07, 2025
Update On Letter Dated April 15 2025Apr 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 19, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 07, 2025
Quarterly Update - Q4 FY2024-25Apr 02, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Apr 02, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Apr 01, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Cautionary LetterMar 28, 2025
Corporate Action-Board to consider DividendMar 28, 2025
Board Meeting Intimation for Considering Of Audited Financial Results For The Quarter/Financial Year Ending On 31St March 2025 And Dividend Mar 28, 2025
Closure of Trading WindowMar 28, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMar 21, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 10, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 14, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2025
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 04, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 30, 2025
Integrated Filing (Financial)Jan 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2025
Submission Of Information Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2025
Unaudited Financial And Segment-Wise Results For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Board Meeting Outcome for Unaudited Financial And Segment-Wise Results For The Quarter And Nine Months Ended December 31 2024Jan 30, 2025
Intimation Under Regulation 6 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2025

Technical Indicators

RSI(14)
Neutral
42.08
ATR(14)
Less Volatile
8.13
STOCH(9,6)
Neutral
22.46
STOCH RSI(14)
Neutral
20.90
MACD(12,26)
Bearish
-1.77
ADX(14)
Weak Trend
13.37
UO(9)
Bearish
38.98
ROC(12)
Downtrend And Accelerating
-2.94
WillR(14)
Oversold
-80.23

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Mid-Cap Opportunities Fund Direct-Growth
0.35%
2682432
0.15%
0.14%
Kotak Equity Arbitrage Fund Direct-Growth
0.24%
-1356250
-0.12%
0.15%
ICICI Prudential Large & Mid Cap Fund Direct Plan-Growth
0.60%
1233880
0.25%
0.22%
ICICI Prudential Value Direct-Growth
1.32%
1201712
0.06%
0.12%
Kotak Equity Savings Fund Direct-Growth
0.04%
-1146250
-0.68%
-0.72%
Invesco India Arbitrage Fund Direct-Growth
0.28%
978750
0.20%
0.15%
ICICI Prudential Multicap Fund Direct Plan-Growth
0.77%
756848
0.22%
0.30%
Aditya Birla Sun Life Frontline Equity Direct Fund-Growth
0.75%
-753517
-0.15%
-0.22%
ICICI Prudential Multi Asset Fund Direct-Growth
0.24%
700000
0.05%
0.03%
Tata India Consumer Fund Direct-Growth
1.02%
500000
1.02%
1.02%
SBI Arbitrage Opportunities Fund Direct-Growth
0.21%
436250
0.05%
0.10%
Bandhan Arbitrage Fund Direct-Growth
0.32%
390000
0.20%
0.31%
Tata Arbitrage Fund Direct - Growth
0.28%
381250
0.10%
0.24%
ICICI Prudential Equity Arbitrage Direct-Growth
0.11%
365000
0.06%
0.06%
Edelweiss Arbitrage Fund Direct-Growth
0.21%
328750
0.10%
0.13%
Nippon India Arbitrage Fund Direct-Growth
0.14%
225000
0.07%
0.06%
ICICI Prudential Innovation Fund Direct - Growth
0.87%
-180000
-0.17%
0.05%
Aditya Birla Sun Life Arbitrage Fund Direct-Growth
0.04%
135000
0.04%
0.04%
ITI Large Cap Fund Direct - Growth
0.00%
-122949
-1.16%
-1.32%
Aditya Birla Sun Life India GenNext Direct Fund-Growth
0.83%
-100000
-0.10%
-0.20%
Aditya Birla Sun Life Balanced Advantage Fund Direct-Growth
0.00%
-91250
-0.06%
-0.06%
Axis Arbitrage Fund Direct-Growth
0.19%
71250
0.04%
0.05%
HDFC Arbitrage Fund Wholesale Direct-Growth
0.05%
63750
0.01%
0.02%
UTI Arbitrage Fund Direct-Growth
0.22%
52500
0.02%
0.20%
Bandhan Nifty100 Low Volatility 30 Index Fund Direct-Growth
2.73%
39968
-0.05%
-0.27%

About Dabur

Dabur India Ltd is a leading FMCG company specializing in Ayurvedic and natural products. It operates in categories including hair care, oral care, health care, skin care, home care, and foods. The company has over 250 herbal and Ayurvedic products under brands like Dabur, Vatika, Hajmola, Real, and Fem. Dabur has 20 manufacturing facilities globally, with 12 in India. Its distribution network covers 6.9 million retail outlets in India and its products are available in over 120 countries. The company's portfolio includes health supplements, oral care products, juices, skin care items, and Ayurvedic medicines. Dabur has expanded through acquisitions and new product launches in various categories. It has also entered partnerships for global expansion and launched online sales platforms. The company focuses on innovation, introducing products like Ayurvedic tablets, herbal toothpastes, and immunity-boosting juices.
Chairperson NameMohit Burman